Your Health, We Care
Ceritinib is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
from FDA，2021.10
LuciusVersionofCeritinib:DosageandAdministration,Indications,PrecautionsIndicationsCeritinib is a ki···【more】
Recommended：592025-12-12
Suitable for treating adult patients with metastatic non-small cell lung cancer (NSCLC).【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：6
LuciusVersionofCeritinib:DosageandAdministration,Indications,PrecautionsIndicationsCeritinib is a kinase inhibitor indicated for the treatment of adult patients with metastatic non···【more】
Article source：Lucius LaosRelease date：2025-12-12Recommended：59
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
